Agoracom Blog Home

Posts Tagged ‘CSE’

PhytoPain Pharma Announces Interview With Radio-Canada Regarding Its Development of a Prescription Marijuana Drug $GCI.ca

Posted by AGORACOM-JC at 9:28 AM on Thursday, September 22nd, 2016

Growpros_hub_large

OTTAWA, ONTARIO–(Sept. 22, 2016) – PhytoPain Pharma (“PPP”), a subsidiary of GrowPros Cannabis Ventures Inc. (“GrowPros” or the “Company” or “GCI“) (CSE:GCI), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain and other medical conditions announces that it gave an interview to the journalist Brigitte Bureau of Radio-Canada regarding the development of a prescription marijuana drug. Shareholders can view the interview on CBC’s website at http://ici.radio-canada.ca/regions/ottawa/2016/09/21/008-marijuana-medicinale-legalisation-gouvernement-trudeau.shtml

According to Dr. G. Chamberland, Chief Scientific Officer, “PPP is developing a prescription drug marijuana product for consumption via inhalation “smoking”. As part of its mission of bringing botanical-based therapies to patients with chronic diseases while maintaining the characteristics and properties of natural health products but backed by the scientific research and development of Pharma industry. Over the next years, the corporation is planning to develop the evidence to support the prescription of marijuana by physicians and to seek coverage by provincial and federal insurers.” “By implementing this approach, we believe that PPP is addressing the missing link that has existed for years as the major barrier of access to medical cannabis by both patients and physicians across the globe“, commented Ryan Brown, Vice-President of Business Development and Director of Communications for GCI.

Dr. Chamberland further commented that the company intends on submitting a Clinical Trial Application later this year (pre-CTA submitted in August 2016 as per previous news release) and when authorized by Health Canada would initiate its Phase I trial in humans later this year. “PPP001 is in its early stages of development, but based on published clinical trial data, the company is confident that it can bring this product to the market after completing the studies required by regulatory agencies“, commented Dr. Chamberland.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

GrowPros Cannabis Ventures Inc.
Dr. Guy Chamberland
Chief Scientific Officer
(514) 220-9225

GrowPros Cannabis Ventures Inc.
Andre Audet
Executive Chairman
(613) 421-8402

GrowPros Cannabis Ventures Inc.
Ryan Brown
President, GrowPros MMP Inc.
(613) 421-8402

VGambling Securities Are Now DWAC/FAST Eligible With DTC; eSports Investors Now Able to Electronically Buy, Sell and Transfer Shares $GMBL

Posted by AGORACOM-JC at 8:36 AM on Wednesday, September 21st, 2016

Vgabmlinglarge_copy

  • Depository Trust Corporation (the “DTC”) has approved its common stock for DWAC/FAST transfer through the Company’s Transfer Agent, Transhare Corporation
  • Newly approved stock transfer capability will enable VGambling Inc. shareholders to transfer their shares of GMBL stock electronically after buying or selling on the open market
  • No extra expense and delay associated with the processing and transfer of physical share certificates

ST. MARY’S, ANTIGUA–(Sep 21, 2016) – VGambling Inc. (OTCQB: GMBL) (or the “Company”), a licensed online gambling company with a specific focus on eSports wagering, is pleased to announce today the Depository Trust Corporation (the “DTC”) has approved its common stock for DWAC/FAST transfer through the Company’s Transfer Agent, Transhare Corporation. This newly approved stock transfer capability will enable VGambling Inc. shareholders to transfer their shares of GMBL stock electronically after buying or selling on the open market, without the extra expense and delay associated with the processing and transfer of physical share certificates.

Companies approved for DWAC/FAST electronic transfers often experience higher trading volumes in their stock given the additional accessibility and availability of shares for trading.

Grant Johnson, CEO of VGambling Inc., stated, “We are pleased to announce another shareholder-friendly step in our evolution as an eSports public company. DWAC transfer eligibility enables our shareholders to maintain the highest levels of efficiency, accountability and compliance standards for their trading activities in our shares through the best and most up-to-date electronic securities trading platforms being used today. This is especially important to eSports investors that span the globe but have few options for publicly traded eSports focused companies such as VGambling.”

About VGambling Inc.

VGambling Inc. is an online gambling company specifically focused on eSports. VGambling intends to offer eSports wagering on a fully licensed, regulated and secured platform to the global eSports audience. VGambling is led by a team of industry and technical experts from the online gambling and video game industries, e-Sports, marketing, legal and financial professionals. The Company maintains offices in St. Mary’s, Antigua and Barbuda. VGambling is currently developing several play money websites and their real money wagering website.

About VGambling Licensing, Compliance And Regulatory Process

1. VGambling has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission.

2. VGambling has entered into a Betting Gaming Platform Software Agreement with Swiss Interactive Software GmbH to provide wagering platform software.

3. VGambling has an agreement with CAMS, LLC to provide global electronic payment and risk management solutions.

4. VGambling has agreed to integrate the award-winning affiliate management platform of Income Access to manage the Company’s forthcoming affiliate program.

VGambling common stock is listedon the OTCQB under the symbol GMBL. For more information, please see www.vgambling.net

Contact:
Grant Johnson
Chief Executive Officer
[email protected]

GrowPros Changes Its Name to Tetra Bio-Pharma Inc. and Announces the Results of Its Annual Shareholders Meeting $GCI.ca

Posted by AGORACOM-JC at 4:39 PM on Monday, September 19th, 2016

Growpros_hub_large

  • Selected Tetra Bio-Pharma Inc. as the new name for the Company
  • Company also announces the re-appointment of Mr. André Audet as Director of GrowPros and welcomes three new directors on its Board, Mr. André Rancourt, Mr. Robert Brouillette, and Mr. Benoit Chotard.

OTTAWA, ONTARIO–(Sept. 19, 2016) – GrowPros Cannabis Ventures Inc. (“GrowPros” or “the Company”) (CSE:GCI) is pleased to announce that its shareholders have approved an amendment to the Company’s articles of incorporation in order to change its name. The Board of Directors, at a special meeting following the annual shareholders meeting, has selected Tetra Bio-Pharma Inc. as the new name for the Company.

The Company also announces the re-appointment of Mr. André Audet as Director of GrowPros and welcomes three new directors on its Board, Mr. André Rancourt, Mr. Robert Brouillette, and Mr. Benoit Chotard. (Reference to News Release of August 25, 2016)

The firm of McGovern Hurley Cunningham, LLP, was re-appointed as auditors of the Company.

Shareholders have approved the Board’s request for consolidation of the share capital of the Company on the basis of a consolidation ratio of one (1) post-consolidation share for every three (3) pre-consolidation shares. As previously released the consolidation will only be implemented in the case of a major business development.

Non-Brokered Private Placement

The Company also announces a non-brokered private placement (the “Offering”) comprised of 5,000,000 units at a price of $0.05 per unit for gross proceeds of $250,000. Each unit will consist of one common share and one transferable warrant. Each warrant entitles the holder to purchase one common share at a price of $0.07 for a period of twenty-four months following the closing of the Offering. All securities issued pursuant to the private placement are subject to a four-month hold period from the closing date and are subject to all necessary regulatory approvals.

In connection with the private placement, the Company may pay finder’s fees.

The proceeds of the private placement will be used to fund general working capital.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

GrowPros Cannabis Ventures Inc.
Andre Rancourt
Interim Chief Executive Officer
(613) 421-8402

GrowPros Cannabis Ventures Inc.
Andre Audet
Chairman
(613) 421-8402

GrowPros Cannabis Ventures Inc.
Ryan Brown
Grow Pros MMP Inc. President
(613) 421-8402

Namaste Technologies Inc. (N:CSE) Halted, Pending News $N.ca

Posted by AGORACOM-JC at 8:08 AM on Thursday, September 15th, 2016

Namastelarge_copy

TORONTO, Sept. 15, 2016 /CNW/ – The following issues have been halted by IIROC:

Company: Namaste Technologies Inc.

CSE Symbol: N

Reason: Pending News

Halt Time (ET): 7:43 AM ET

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

IIROC Inquiries 1-877-442-4322 (Option 2) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.Copyright CNW Group 2016

 

FEATURE: #1 Vaporizer Distributor in Europe, $5.8M USD of Revenue Run Rate $N.ca

Posted by AGORACOM-JC at 5:25 PM on Wednesday, September 14th, 2016

Namastelarge_copy

  • #1 vaporizer distributor in Europe
  • $5.8M USD of revenue run rate
  • Proprietary products launched
  • Perfect market timing for expansion

  • International ecommerce distribution
  • 30+ International based portals
  • 10 Languages
  • Proprietary vaporizer products
  • Targeting organic growth at 100% per year
  • Sourcing accretive M & A transactions

Regulation

  • Decriminalization and destigmatization of marijuana for medical and recreational use in US, Canada and Europe
  • Vaporizers have lower regulatory burden than growers

Health Advantages

Technical Advances

  • Improved mobility from reduced size of vaporizers
  • Ability to handle liquids, resins and plant matters
  • Conduction, convection, induction technologies
  • Mobile connectivity
  • Increasingly becoming part of the internet of things

 

Data: All China’s new power demand met by wind and solar last year $HPQ.ca

Posted by AGORACOM-JC at 10:39 AM on Thursday, September 8th, 2016

  • China dramatically increased the portion of its electricity generated from wind and solar in 2015
  • Growth in the two forms of power alone exceeding the rise in the country’s total electricity demand.

China dramatically increased the portion of its electricity generated from wind and solar in 2015, with the growth in the two forms of power alone exceeding the rise in the country’s total electricity demand.

China: Six little known facts about the country’s solar and wind boom

New data collated by Greenpeace shows that the country’s electricity consumption rose 0.5% last year, from 5522 TWh (terawatt hours) to 5550 TWh.

Wind and solar comfortably met this new demand, producing 186.3 TWh and 38.3 TWh of electricity in 2015, compared to 153.4 TWh and 23.3 TWh the year before. That’s a dramatic increase: 21% and 64%, respectively.

Lauri Ch

To give those numbers more context, China’s increase in power generation from wind and solar in 2015 (48 TWh) alone was twice Ireland’s entire electricity demand the previous year (24 TWh).

Half UK energy needs

In fact, Chinese wind alone could have met more than half the UK’s entire energy needs in 2015 (304 TWh).

The expansion of renewable energy generation was made possible by China vastly increasing its wind and solar capacity in 2015, up 28% and 54% respectively on 12 months previously. In total, the country made up nearly half of the world’s new solar and wind capacity last year.

Lauri chart 2

Coal use falls

The increased use of renewable energy, together with a marked economic shift away from heavy industry sectors, has meant that coal use in the country has dropped for a third year in a row, though it is still the biggest source of global CO2 emissions.

Last week, China announced that it was ratifying the Paris climate agreement, alongside the United States, in a move widely hailed as historic.

With the American presidential election now just two months away, it remains to be seen whether the States will be able to catch up in the race to lead the post-fossil fuels global economy.

Source: http://energydesk.greenpeace.org/2016/09/08/data-chinas-new-power-demand-met-wind-solar-last-year/

GCI Subsiduary PhytoPain Pharma Announces Submission of Orphan Drug Designation Application for Delta-9-tetrahydrocannibinol and Cannabidiol in the United States $GCI.ca

Posted by AGORACOM-JC at 8:53 AM on Tuesday, September 6th, 2016

Growpros_hub_large

  • Submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development,
  • Two applications for Orphan Drug Designation for delta-9-tetrahydrocannibinol and cannabidiol for the treatment of patients with Complex Regional Pain Syndrome Type 1 (CRPS1) and patients with Central PostStroke Pain (CPSP).

OTTAWA, ONTARIO–(Sept. 6, 2016) – PhytoPain Pharma Inc. (“PhytoPain Pharma” or “PPP“), a subsidiary of GrowPros Cannabis Ventures Inc. (“GrowPros” or the “Company“) (CSE:GCI), today announces the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, two applications for Orphan Drug Designation for delta-9-tetrahydrocannibinol and cannabidiol for the treatment of patients with Complex Regional Pain Syndrome Type 1 (CRPS1) and patients with Central PostStroke Pain (CPSP). The decision to proceed with these Orphan Drug Designation submissions is part of PPP’s plan to move forward with the development of a cannabis prescription drug product for the treatment of neuropathic pain associated with CRPS1 and CPSP. If successful, the designation of delta-9-tetrahydrocannibinol and cannabidiol as an Orphan Drug will open the door for many opportunities most notably tax credits on clinical research reduction of the waiting period and reduced registration fees. It also provides PPP with a 7-year period of market exclusivity in the U.S.

Dr. Guy Chamberland, M.Sc., Ph.D., Chief Scientific Officer of PhytoPain Pharma, commented: “Our Orphan Drug Designation submissions, announced today, are part of our corporate strategy to develop and commercialize delta-9-tetrahydrocannibinol and cannabidiol prescription drug products for the management of neuropathic pain associated with cancer, HIV, CPSP, and CRPS1 and uncontrolled pain within the United States.” He continued: “I am also very pleased to report that PPP and its collaborators are on track to finalize the Clinical Trial Application (CTA) and submit the clinical protocol to the US Food & Drug Administration (FDA) for review. PPP is developing these prescription drug products for both the Canadian and USA market and intends on obtaining marketing approval from Health Canada and the US FDA. Our medical research team headed by Apical Science Inc. principals Dr. Randy Ringuette, Ph.D. and Dr. Charles Campbell, Ph.D. has been tasked with finalizing these documents for the regulatory agencies.

“This important step positions PPP at the forefront of North American cannabis based consumer drug product development. PPP intends to engage industry partners operating under Canada’s ACMPR (Access to Cannabis for Medical Purposed Regulation) to participate in various aspects of the development process. Being able to leverage this federally legal infrastructure will allow PPP many benefits not available in other jurisdictions”, commented GrowPros CEO Ryan Brown.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Contact Information

  • GrowPros Cannabis Ventures Inc.
    Ryan Brown
    Chief Executive Officer
    (613) 421-8402GrowPros Cannabis Ventures Inc.
    André Audet
    Executive Chairman
    (613) 421-8402

    GrowPros Cannabis Ventures Inc.
    Dr. Guy Chamberland
    Chief Scientific Officer and Regulatory Affairs
    (514) 220-9225

AGORACOM Welcomes Marijuana Company of America (MCOA:OTC) At The Forefront Of Hemp Marketing And Distribution $MCOA.us

Posted by AGORACOM-JC at 8:41 AM on Tuesday, September 6th, 2016

15233_mcoa

MCOA: OTC

WHY MCOA?

  • Recently launched Club Harmoneous to provide product distribution services to its members
  • Services provided include product sourcing, processing, product development, marketing, branding, distribution, delivery and customer loyalty through direct sales
  • Recently launched the BudzPlus brand, focused on the medical and recreational marijuana markets
  • In process of launching the HempSmart product line to distribute its hemp-derived products

COMPANY SUMMARY

  • Cannabis and hemp marketing and distribution company that offers premium quality seed-to-solution products for the cannabis and hemp industry and consumers.
  • Delivering all the benefits of cannabis by focusing on ailment-specific, leisure-specific, and health & beauty-specific cannabis product applications.
  • Product sourcing, branding, payment, distribution, and knowledge through a revolutionary architecture to maintain customer loyalty and capture market share.

PRODUCTS

MCOA procures and distributes cannabis and hemp products through a direct sales platform and its Club Harmoneous brand. In legal medical marijuana states, MCOA affiliates will refer consumers to a collective/dispensary. The Company will offer a wide selection of cannabis and hemp derived products. The Company will deliver top quality cannabis products at competitive prices, which will be on the lower end of current market prices.

The Company is also preparing to launch its first proprietary hemp-derived CBD product in Q3 2016. MCOA plans to expand the HempSmart brand and continue to develop and launch new proprietary cannabinoid products on a quarterly basis thereafter.

HempSmart will launch proprietary blended formulations of cannabinoid nutraceutical products for Energy, Sleep, Relaxation, Immunity, Pain, Hair Growth, body care and cosmetic products, food, clothing and more.

THE MARKET

  • Growth in the cannabis industry has been building momentum for more than 5 years. Overwhelming public support is helping fuel exponential growth.
  • Consumers are able to access factual information regarding cannabis, they are less likely to believe the baseless propaganda that is spewed by the opponents of legalization.
  • Dr. Gupta, CNN’s Chief Correspondent, said that he now believes that cannabis does in fact help people.
  • Comments generated significant media coverage around the world. He has since doubled down with a second and third follow up documentaries on cannabis.

Gupta: ‘I am doubling down’ on medical marijuana


Medical marijuana and ‘the entourage effect’

  • Recreational marijuana sales in Colorado and Washington State could top half a billion dollars;
  • The recreational market is expected to continue growing rapidly as more states legalize cannabis, reaching approximately $4.2 billion in 2018;
  • Florida and other unexpected states like Texas could legalize cannabis in 12-18 months, creating scores of new business and investment opportunities;
  • Ancillary industries and companies (those that do not touch the plant) generate hundreds of millions of dollars annually, in additional revenues and will continue to expand alongside cannabis sales;
  • Combined recreational cannabis sales could total an estimated $40-$45 billion, if cannabis is legalized across the United States.

MCOA NEWS CLIPS
12 MONTH STOCK CHART
Chart Image

VIDEO: eSports Investing AGORACOM at League of Legends Finals $GMBL

Posted by AGORACOM-JC at 6:13 PM on Wednesday, August 31st, 2016

 eSports Investing AGORACOM at League of Legends Finals

With eSports investing starting to heat up and investors asking questions, AGORACOM went to the League Of Legends North American Summer Finals in Toronto to do some research and see for ourselves just how real the space is. We were blown away. A sold out Air Canada Centre, more than 1 million people tuning in online, screaming and cherring fans … all for video gamers turned rock stars.

eSports is real. It is the future of sports, whether you like it or not. 200 million people are watching and wagering on eSports TODAY. In 3 years, it will have surpassed every major professional sport but soccer. If you ever fantasized about being an investor in the early days of the NFL, NBA or NHL, then eSports is your opportunity to actually live that dream.

Who to invest in? Follow the links to $GMBL below.

AGORACOM is your starting point. Everybody is going to be a winner.

Hub On AGORACOM / Corporate Profile / Watch Video

ACC - 0816 ACC - 0816b ACC - 0816c ACC - 0816d

Nevada Energy Metals Lithium Exploration Program Underway at Black Rock Desert, Nevada $BFF.ca

Posted by AGORACOM-JC at 8:41 AM on Monday, August 29th, 2016

Bff_hub-2_copy

  • Surface sampling program designed to test for lithium values in playa evaporates has been initiated at the Company’s 100% owned Black Rock Desert Project
  • Geochemical sample points are being arranged on a grid pattern of 11 lines spaced 400 meters apart with stations every 200 meters along the lines

August 29, 2016 / Nevada Energy Metals Inc. “the Company” (TSX-V: BFF; OTCQB: SSMLF; Frankfurt: A2AFBV) is pleased to announce that a surface sampling program designed to test for lithium values in playa evaporates has been initiated at the Company’s 100% owned Black Rock Desert Project. Geochemical sample points are being arranged on a grid pattern of 11 lines spaced 400 meters apart with stations every 200 meters along the lines. It is expected that 170 sample points will be measured. Results should be available in approximately 3 weeks.

The Black Rock Desert Lithium Project consists of 128 placer claims, (2,560 acres/ 1,036 hectares) located in southwest Black Rock Desert, Washoe County, Nevada. The nearest population center is the town of Gerlach, which lies 177 kilometers north of Reno.

The western arm of the Black Rock Desert covers an area of about 2,000 square kilometers and contains 5 of the 30 currently listed Known Geothermal Resource Areas in Nevada. The property covers an area of playa underlain by a moderately deep basin interpreted from gravity and seismic surveys indicating a maximum thickness of valley-fill deposits of about 1,200 m/ 3,600 ft. A high salt content prevents any significant vegetation from growing on the playa surface. Locally, the basin is being fed in part by boiling springs and siliceous sinter containing strongly anomalous Lithium values (up to 3.5 ppm) that flank the property on the west side. (U.S. GEOLOGICAL SURVEY Open-File Report 81-918.) While these lithium values are well below those of producing lithium bines, they do represent a significant source of metal available for evaporative concentration within the playa basin.

The company plans to carry out additional exploration programs this fall to determine the potential for an economic lithium brine deposit. Future exploration will consist of shallow auger sampling followed by a high resolution geophysical program to define potential drill targets.

Nevada Energy Metals has acquired a 100% interest in the property, free of royalty payments.

Qualified Person: The technical content of this news release has been reviewed and approved by Alan Morris CPG, Elko, Nevada

About Nevada Energy Metals: http://nevadaenergymetals.com/

Nevada Energy Metals Inc. is a well funded, Canadian based, exploration company who’s primary listing is on the TSX Venture Exchange. The Company’s main exploration focus is directed at lithium brine targets located in the mining friendly state of Nevada. The Company has ownership of 77 claims in Clayton Valley, only 250m from Rockwood Lithium, the only brine based lithium producer in North America (70% optioned-out to American Lithium Corp (TSX-V: Li). Nevada Energy Metals has also acquired: 100 claims (Teels Marsh West) covering 2000 acres (809 hectares) at Teels Marsh, Mineral County, Nevada, a prospective lithium exploration project, 100% owned without any royalties; the San Emidio Desert lithium project, consisting of 155 claims (approximately 3,100 acres/1255 hectares) in Washoe County, Nevada; the Alkali Lake Project in Esmeralda county, is a 60% earn in option agreement from Dajin Resources Corp (TSX-V: DJI), where near surface lithium values have been confirmed; the Dixie Valley Project consisting of 907 claims covering 73.6 square kilometers/28.4 square miles (7,363 hectares/18,194 acres) of salt marsh playa. The BSV Lithium Project consists of 160 placer claims, 3,200 acres/1,295 hectares, located in northern Big Smokey Valley. The Black Rock Desert Project consists of 128 placer claims (2,560 acres/ 1,036 hectares) located in southwest Black Rock Desert, Washoe County, Nevada.

On Behalf of the Board of Directors:

Rick Wilson, President & CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the contents of this release.

Disclaimer for Forward-Looking Information:

The information discussed in this press release may include “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). All statements, other than statements of historical facts, included herein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. These forward looking statements are identified by their use of terms and phrases such as “may,” “expect,” “estimate,” “project,” “plan,” “believe,” “intend,” “achievable,” “anticipate,” “will,” “continue,” “potential,” “should,” “could,” and similar terms and phrases. Although we believe that the expectations reflected in these forward looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not be considered to be) guarantees of future performance. It is important that each person reviewing this release understand the significant risks attendant to the operations of the Company. Nevada Energy Metals Inc. disclaims any obligation to update any forward-looking statement made herein.